Fact CheckerSign in

NCT03968055Active, not recruiting

Remote Monitoring of CGM Data in Pediatric Patients With Newly Diagnosed Type 1 Diabetes (T1D)

The Use of Continuous Glucose Monitor Technology and Remote Monitoring to Change Clinical Outcomes Following New Diagnosis of Type 1 Diabetes in the Pediatric Population

Source: ClinicalTrials.gov · Last updated 8 May 2026

Brief summary (registry, in English)

To determine if increased targeted contact between patients and the care team can improve diabetes outcomes in the 1st year after diagnosis. We will be using the GluVue platform to remotely view continuous glucose monitor (CGM) data.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
100 (estimated)
First submitted
28 May 2019
Start date
25 Mar 2019
Primary completion date
30 Dec 2025
Lead sponsor
Stanford University
NCT number
NCT03968055

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 25 Mar 2019 to the primary completion date, 30 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Diagnosis of diabetes \> 1 month prior to initial visit

Other illness

  • Diabetes diagnosis other than T1D
  • Individuals with the intention of obtaining diabetes care at another clinic

Age

  • Individuals \> 21 years of age

Other

  • Individuals who do not consent to CGM use, CGM data integration, or remote monitoring

Who the study is looking for

  • All individuals within one month of T1D diagnosis seen at the Stanford Children's Diabetes Clinic
  • Individuals who plan to receive follow up care at the Stanford Children's Diabetes Clinic
  • Individuals who agree to CGM data integration into the electronic medical record (EMR) for remote monitoring
  • Age: birth to \< 21 years of age

Age in the registry: 6 months to 21 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Lucile Packard Children's Hospital
Coordinator of this site? Confirm its status
Palo AltoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.